BFM
DCPH

Boothbay Fund Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Boothbay Fund Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-31,000
Closed -$1.05M – 2306
2021
Q3 		$1.05M Buy
+31,000
New +$989K 0.03% 735
2020
Q4 		– Sell
-72
Closed -$369K – 1470
2020
Q3 		$369K Hold
72
– – 0.02% 756
2020
Q2 		$430K Buy
+72
New +$3.85K 0.03% 616
2019
Q3 		– Sell
-681
Closed -$1.54M – 936
2019
Q2 		$1.54M Buy
+681
New +$15.9K 0.14% 184

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's DCPH Position: Q3 2023 in Review

Boothbay Fund Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2023, closing a stake of 30,236 shares — an estimated $426K sold.

Boothbay Fund Management first reported a position in DCPH in Q3 2018 and held it in 9 quarters. The position peaked at $1.58M in Q3 2022. 157 funds tracked by Wall St. Rank hold DCPH as of Q3 2023.

  • Boothbay Fund Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 30,236 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $426K.
  • Boothbay Fund Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 9 quarters.
  • Boothbay Fund Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.58M in Q3 2022.
  • 157 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.